Den mediane progressionsfrie overlevelse var 5, 6 måneder (Xeloda + cisplatin) versus 5, 0 måneder (5- FU + cisplatin).
The median progression-free survival was 5.6 months (Xeloda + cisplatin) versus 5.0 months (5-FU + cisplatin).